Market Overview

Citron Research Negative on Life Partners (LPHI)

Share:

Citron Research just gave an update on its view of Life Partners Inc. (NASDAQ: LPHI). The research firm recently said, “Our opinion was that regulation of the life settlements industry would destroy the business of Life Partners. In the opinion of Citron, that day has come.”

The analysts continue to note that Life Partner’s business model only works in an unregulated market, which the SEC has begun to crackdown upon in amazing fashion. Interesting to note, Citron said, “Now, in the sunsetting phase of its business model, as the number of unregulated transaction candidates dries up, its financial statements reveal that LPHI is being forced to close fewer transactions, of larger face value, and carve out for itself an ever larger share of the transaction fees. These fees are now nearly equivalent to the value paid to the seller of the policies – an absurdly high value.”

This is interesting; traders should start researching a short position in the name.

For the entire report, please visit…

http://www.citronresearch.com/index.php/2010/07/28/citron-updates-life-p...

 

Related Articles (LPHI)

View Comments and Join the Discussion!

Posted-In: Citron Research U.S. Securities and Exchange CommissionAnalyst Color Short Sellers Short Ideas Trading Ideas

Latest Ratings

StockFirmActionPT
ATVINeedhamMaintains90.0
AGRMorgan StanleyInitiates Coverage On46.0
ARCOBradescoUpgrades6.0
CARMorgan StanleyUpgrades37.0
EQTCredit SuisseUpgrades
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com